Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial

Abstract Background Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women. Insulin resistance (IR) has emerged as a central contributor to the pathogenesis of this disease. According to traditional Chinese medicine (TCM), kidney deficiency is the main syndrome of PCOS....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Haiqing Qian, Wenting Xu, Lijuan Cui, Rong Wang, Jiahui Wang, Mengyu Tang, Minggang Wei, Lihong Wang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/234d3d8eea79445d8a1fabbc1894471c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:234d3d8eea79445d8a1fabbc1894471c
record_format dspace
spelling oai:doaj.org-article:234d3d8eea79445d8a1fabbc1894471c2021-11-14T12:31:14ZEfficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial10.1186/s13063-021-05770-z1745-6215https://doaj.org/article/234d3d8eea79445d8a1fabbc1894471c2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13063-021-05770-zhttps://doaj.org/toc/1745-6215Abstract Background Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women. Insulin resistance (IR) has emerged as a central contributor to the pathogenesis of this disease. According to traditional Chinese medicine (TCM), kidney deficiency is the main syndrome of PCOS. The deficiency of the kidney cannot vaporize water-dampness, and the retention of water-dampness accumulates into phlegm dampness stagnation, resulting in visceral dysfunction and metabolic disorder. TCM involving syndrome differentiation and treatment is widely used to adjust women’s menstrual cycles. Our patented formula Bushen Huatan Decoction (BSHTD) has been proven to be effective in the clinical treatment of IR-PCOS. Baduanjin also plays an important role in improving metabolic syndrome through lifestyle intervention. This study investigates the clinical efficacy of Bushen Huatan Decoction combined with Baduanjin in IR-PCOS, to form a specific TCM-behaviour intervention plan in the treatment of IR-PCOS. Methods/design This is a randomized controlled trial involving 190 participants diagnosed with IR-PCOS. All participants will be randomly allocated into 5 groups: group A will receive metformin; group B, BSHTD; group C, Baduanjin; group D, BSHTD combined with metformin; and group E, BSHTD combined with Baduanjin. One course of treatment lasts 3 months, a total of two courses. The primary outcomes are changes in the homeostatic model assessment of insulin resistance (HOMA-IR) and improvements in the oral glucose tolerance test (OGTT) and insulin-releasing test (INS). The secondary outcomes are improvements in the menstrual cycle, ovulation rate, clinical pregnancy rate, basic serum sex hormone levels, free androgen index (FAI), Ferriman-Gallwey scores, body mass index (BMI) and TCM syndrome scores. The related observation indexes will be collected at baseline, during the process of treatment and at the 6-month follow-up. Simultaneously, close monitoring of possible adverse events will be performed throughout the trial process. Discussion This trial will investigate the efficacy of the comprehensive intervention program of Bushen Huatan Decoction combined with Baduanjin on the adjustment of the menstrual cycle, improvement of insulin resistance and correction of glucose metabolism disorder in IR-PCOS patients. It is expected to form an alternative treatment of TCM-behaviour intervention therapy for IR-PCOS and promote the Chinese fitness Qigong Baduanjin in the application of lifestyle diseases. Trial registration Chinese Clinical Trial Registry ChiCTR2100043415 . Registered on 15 February 2021.Haiqing QianWenting XuLijuan CuiRong WangJiahui WangMengyu TangMinggang WeiLihong WangBMCarticlePolycystic ovary syndromeInsulin resistanceBushen Huatan DecoctionBaduanjinMedicine (General)R5-920ENTrials, Vol 22, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Polycystic ovary syndrome
Insulin resistance
Bushen Huatan Decoction
Baduanjin
Medicine (General)
R5-920
spellingShingle Polycystic ovary syndrome
Insulin resistance
Bushen Huatan Decoction
Baduanjin
Medicine (General)
R5-920
Haiqing Qian
Wenting Xu
Lijuan Cui
Rong Wang
Jiahui Wang
Mengyu Tang
Minggang Wei
Lihong Wang
Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
description Abstract Background Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women. Insulin resistance (IR) has emerged as a central contributor to the pathogenesis of this disease. According to traditional Chinese medicine (TCM), kidney deficiency is the main syndrome of PCOS. The deficiency of the kidney cannot vaporize water-dampness, and the retention of water-dampness accumulates into phlegm dampness stagnation, resulting in visceral dysfunction and metabolic disorder. TCM involving syndrome differentiation and treatment is widely used to adjust women’s menstrual cycles. Our patented formula Bushen Huatan Decoction (BSHTD) has been proven to be effective in the clinical treatment of IR-PCOS. Baduanjin also plays an important role in improving metabolic syndrome through lifestyle intervention. This study investigates the clinical efficacy of Bushen Huatan Decoction combined with Baduanjin in IR-PCOS, to form a specific TCM-behaviour intervention plan in the treatment of IR-PCOS. Methods/design This is a randomized controlled trial involving 190 participants diagnosed with IR-PCOS. All participants will be randomly allocated into 5 groups: group A will receive metformin; group B, BSHTD; group C, Baduanjin; group D, BSHTD combined with metformin; and group E, BSHTD combined with Baduanjin. One course of treatment lasts 3 months, a total of two courses. The primary outcomes are changes in the homeostatic model assessment of insulin resistance (HOMA-IR) and improvements in the oral glucose tolerance test (OGTT) and insulin-releasing test (INS). The secondary outcomes are improvements in the menstrual cycle, ovulation rate, clinical pregnancy rate, basic serum sex hormone levels, free androgen index (FAI), Ferriman-Gallwey scores, body mass index (BMI) and TCM syndrome scores. The related observation indexes will be collected at baseline, during the process of treatment and at the 6-month follow-up. Simultaneously, close monitoring of possible adverse events will be performed throughout the trial process. Discussion This trial will investigate the efficacy of the comprehensive intervention program of Bushen Huatan Decoction combined with Baduanjin on the adjustment of the menstrual cycle, improvement of insulin resistance and correction of glucose metabolism disorder in IR-PCOS patients. It is expected to form an alternative treatment of TCM-behaviour intervention therapy for IR-PCOS and promote the Chinese fitness Qigong Baduanjin in the application of lifestyle diseases. Trial registration Chinese Clinical Trial Registry ChiCTR2100043415 . Registered on 15 February 2021.
format article
author Haiqing Qian
Wenting Xu
Lijuan Cui
Rong Wang
Jiahui Wang
Mengyu Tang
Minggang Wei
Lihong Wang
author_facet Haiqing Qian
Wenting Xu
Lijuan Cui
Rong Wang
Jiahui Wang
Mengyu Tang
Minggang Wei
Lihong Wang
author_sort Haiqing Qian
title Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
title_short Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
title_full Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
title_fullStr Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
title_full_unstemmed Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
title_sort efficacy of bushen huatan decoction combined with baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (ir-pcos), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial
publisher BMC
publishDate 2021
url https://doaj.org/article/234d3d8eea79445d8a1fabbc1894471c
work_keys_str_mv AT haiqingqian efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT wentingxu efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT lijuancui efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT rongwang efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT jiahuiwang efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT mengyutang efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT minggangwei efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
AT lihongwang efficacyofbushenhuatandecoctioncombinedwithbaduanjininthetreatmentofpolycysticovarysyndromewithinsulinresistanceirpcoskidneydeficiencyandphlegmdampnessstudyprotocolforarandomizedcontrolledtrial
_version_ 1718429153954365440